Exaggerated human monocyte IL-10 concomitant to minimal TNF-alpha induction by heat-shock protein 27 (Hsp27) suggests Hsp27 is primarily an antiinflammatory stimulus
| dc.contributor.author | De, Asit K. | |
| dc.contributor.author | Kodys, Karen | |
| dc.contributor.author | Yeh, Berhan S. | |
| dc.contributor.author | Miller-Graziano, Carol L. | |
| dc.date | 2022-08-11T08:09:31.000 | |
| dc.date.accessioned | 2022-08-23T16:34:06Z | |
| dc.date.available | 2022-08-23T16:34:06Z | |
| dc.date.issued | 2000-10-18 | |
| dc.date.submitted | 2009-03-10 | |
| dc.identifier.citation | <p>J Immunol. 2000 Oct 1;165(7):3951-8.</p> | |
| dc.identifier.issn | 0022-1767 (Print) | |
| dc.identifier.doi | 10.4049/jimmunol.165.7.3951 | |
| dc.identifier.pmid | 11034403 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.14038/38258 | |
| dc.description.abstract | Unlike more well-studied large heat shock proteins (hsp) that induce both T cell antiinflammatory (IL-10, IL-4) and macrophage proinflammatory (TNF-alpha, IL-15, IL-12) cytokines, hsp27, a small hsp, has been primarily identified as a substrate of mitogen-activated protein kinase-activated protein kinase-2 involved in the p38 signaling pathway and activated during monocyte IL-10 production. Hsp27 can also act as an endogenous protein circulating in the serum of breast cancer patients and a protein whose induction correlates to protection from LPS shock. However, the cytokine-stimulating properties of hsp27 have been unexplored. In this study, exogenous hsp27 is demonstrated for the first time as a potent activator of human monocyte IL-10 production, but only a modest inducer of TNF-alpha. Although exogenous hsp27 stimulation activated all three monocyte mitogen-activated protein kinase pathways (extracellular signal-related kinase (ERK) 1/2, c-Jun N-terminal kinase, and p38), only p38 activation was sustained and required for hsp27 induction of monocyte IL-10, while both ERK 1/2 and p38 activation were required for induction of TNF-alpha when using the p38 inhibitor SB203580 or the ERK inhibitor PD98059. Hsp27's transient activation of the c-Jun N-terminal kinase pathway, which can down-regulate IL-10, may contribute to its potent IL-10 induction. Hsp27's ERK 1/2 activation was also less sustained than activation by stimuli like LPS, possibly contributing to its modest TNF-alpha induction. The failure of either PD98059 or anti-TNF-alpha Ab to substantially inhibit IL-10 induction implied that hsp27 induces IL-10 via activation of p38 signaling independently of TNF-alpha activation and may be predominantly an antiinflammatory monokine stimulus. | |
| dc.language.iso | en_US | |
| dc.relation | <p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=11034403&dopt=Abstract">Link to Article in PubMed</a></p> | |
| dc.relation.url | https://doi.org/10.4049/jimmunol.165.7.3951 | |
| dc.subject | Adjuvants, Immunologic | |
| dc.subject | Anti-Inflammatory Agents, | |
| dc.subject | Non-Steroidal | |
| dc.subject | Cell Separation | |
| dc.subject | Dose-Response Relationship, Immunologic | |
| dc.subject | Enzyme Activation | |
| dc.subject | *Heat-Shock Proteins | |
| dc.subject | Humans | |
| dc.subject | Interleukin-10 | |
| dc.subject | Lipopolysaccharides | |
| dc.subject | Macrophage Activation | |
| dc.subject | Mitogen-Activated Protein Kinases | |
| dc.subject | Monocytes | |
| dc.subject | Neoplasm Proteins | |
| dc.subject | RNA, Messenger | |
| dc.subject | Tumor Necrosis Factor-alpha | |
| dc.subject | p38 Mitogen-Activated Protein Kinases | |
| dc.subject | Life Sciences | |
| dc.subject | Medicine and Health Sciences | |
| dc.title | Exaggerated human monocyte IL-10 concomitant to minimal TNF-alpha induction by heat-shock protein 27 (Hsp27) suggests Hsp27 is primarily an antiinflammatory stimulus | |
| dc.type | Journal Article | |
| dc.source.journaltitle | Journal of immunology (Baltimore, Md. : 1950) | |
| dc.source.volume | 165 | |
| dc.source.issue | 7 | |
| dc.identifier.legacycoverpage | https://escholarship.umassmed.edu/oapubs/1131 | |
| dc.identifier.contextkey | 770109 | |
| html.description.abstract | <p>Unlike more well-studied large heat shock proteins (hsp) that induce both T cell antiinflammatory (IL-10, IL-4) and macrophage proinflammatory (TNF-alpha, IL-15, IL-12) cytokines, hsp27, a small hsp, has been primarily identified as a substrate of mitogen-activated protein kinase-activated protein kinase-2 involved in the p38 signaling pathway and activated during monocyte IL-10 production. Hsp27 can also act as an endogenous protein circulating in the serum of breast cancer patients and a protein whose induction correlates to protection from LPS shock. However, the cytokine-stimulating properties of hsp27 have been unexplored. In this study, exogenous hsp27 is demonstrated for the first time as a potent activator of human monocyte IL-10 production, but only a modest inducer of TNF-alpha. Although exogenous hsp27 stimulation activated all three monocyte mitogen-activated protein kinase pathways (extracellular signal-related kinase (ERK) 1/2, c-Jun N-terminal kinase, and p38), only p38 activation was sustained and required for hsp27 induction of monocyte IL-10, while both ERK 1/2 and p38 activation were required for induction of TNF-alpha when using the p38 inhibitor SB203580 or the ERK inhibitor PD98059. Hsp27's transient activation of the c-Jun N-terminal kinase pathway, which can down-regulate IL-10, may contribute to its potent IL-10 induction. Hsp27's ERK 1/2 activation was also less sustained than activation by stimuli like LPS, possibly contributing to its modest TNF-alpha induction. The failure of either PD98059 or anti-TNF-alpha Ab to substantially inhibit IL-10 induction implied that hsp27 induces IL-10 via activation of p38 signaling independently of TNF-alpha activation and may be predominantly an antiinflammatory monokine stimulus.</p> | |
| dc.identifier.submissionpath | oapubs/1131 | |
| dc.contributor.department | Department of Medicine, Division of Gastroenterology | |
| dc.contributor.department | Department of Surgery | |
| dc.source.pages | 3951-8 |
